Glaxo and Sanofi Are Discussing $620 Million U.K. Vaccine Deal

(Bloomberg) -- GlaxoSmithKline Plc and Sanofi, partners developing a potential coronavirus vaccine, are discussing a 500 million pound ($620 million) deal to supply the U.K. government with the sho...